Opus Genetics Inc.: H.C. Wainwright raises target price to $14 from $8
IRD•H.C. Wainwright raised its target price for Opus Genetics to $14 from $8.
Related News
Legend Biotech: Barclays cuts target price to $61 from $68
LEGN•
Melius Research cuts CoreWeave target price to $80 from $85
CRWV•
Dauch Corporation: Barclays cuts target price to $6 from $8
DCH•
Ceragon attends Craig-Hallum and Needham investor conferences
CRNT•
‘Positive for AI trade’: CoreWeave results lift Europe's semis
SMH•